Yuanji Xu Selected Research

Yuanji Xu Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 07/2008
15	Nasopharyngeal Carcinoma 07/2023 - 11/2014
7	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2009
5	Esophageal Neoplasms (Esophageal Cancer) 03/2023 - 05/2017
4	Lung Neoplasms (Lung Cancer) 04/2024 - 07/2008
2	Esophageal Squamous Cell Carcinoma 01/2023 - 10/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 03/2013
1	Adenocarcinoma of Lung 10/2023
1	Carcinogenesis 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 05/2017
1	Osteoarthritis 08/2015
1	Arthritis (Polyarthritis) 08/2015
1	Chronic Hepatitis B 09/2014
1	Hepatitis B 09/2014
1	Adenoviridae Infections (Adenovirus Infections) 05/2014
1	Necrosis 05/2011

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2008
8	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2019
4	RNA (Ribonucleic Acid)IBA 07/2023 - 01/2021
3	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2020
2	Circular RNAIBA 04/2024 - 01/2021
2	GoldIBA 01/2022 - 05/2017
2	Competitive Endogenous RNAIBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 12/2016
2	LigandsIBA 07/2019 - 06/2017
2	NucleosidesIBA 01/2019 - 05/2017
2	Messenger RNA (mRNA)IBA 08/2015 - 02/2009
2	Histone Deacetylase InhibitorsIBA 10/2010 - 07/2008
1	Environmental BiomarkersIBA 07/2023
1	squamous cell carcinoma-related antigenIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	N-methyladenosineIBA 01/2022
1	Aurora Kinase AIBA 01/2022
1	maleimideIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	6-methyladenineIBA 01/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2022
1	EnzymesIBA 01/2022
1	GlycosaminoglycansIBA 01/2022
1	CytokinesIBA 01/2022
1	Protamine KinaseIBA 01/2022
1	Uric Acid (Urate)IBA 05/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2019
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2019
1	Sincalide FDA Link 11/2018
1	Indicators and Reagents (Reagents)IBA 06/2017
1	Tumor Biomarkers (Tumor Markers)IBA 05/2017
1	Nucleic AcidsIBA 12/2016
1	DeoxyriboseIBA 12/2016
1	Complementary DNA (cDNA)IBA 08/2015
1	Green Fluorescent ProteinsIBA 08/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2015
1	InterferonsIBA 09/2014
1	Interleukin-12 (IL 12)IBA 09/2014
1	DNA VaccinesIBA 01/2014
1	antigen G250IBA 03/2013
1	LuciferasesIBA 01/2013
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2011
1	celastrolIBA 05/2011
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 10/2010
1	Histones (Histone)IBA 10/2010
1	Oncogene Proteins (Oncogene Protein)IBA 03/2010
1	CalciumIBA 08/2008
1	DepsipeptidesIBA 07/2008
1	Thioredoxin-Disulfide ReductaseIBA 07/2008
1	romidepsin (FK228)FDA Link 07/2008

Therapy/Procedure

8	Radiotherapy 01/2022 - 11/2014
4	Immunotherapy 10/2023 - 01/2014
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2023 - 11/2014
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
3	Therapeutics 01/2022 - 12/2012
2	Induction Chemotherapy 05/2021 - 03/2016
1	Neoadjuvant Therapy 07/2017
1	Gastrostomy 01/2016
1	Chemoradiotherapy 01/2016
1	Brachytherapy 11/2014